Who Paid My Doc
Maxim Mokin
Vascular Neurology Tampa, FL Medical Doctor
NPI 1124337290 CMS profile 1078586
2 Tampa General Cir, 3Rd Floor, Tampa, FL 33606
General payments
$136,745
Research payments
$6,380
Ownership & investment interest
$0
Research they led as principal investigator
$860,033
Through program year 2025, Maxim Mokin of Tampa, FL is reported in the CMS Open Payments database as having received $136,745 across 162 general payments and $6,380 in research payments paid to them. Separately, studies naming them as principal investigator received $860,033 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $16,532 | 25 | |
| 2025 | Research | $2,400 | 3 | |
| 2024 | General | $15,570 | 36 | |
| 2023 | General | $27,883 | 37 | |
| 2022 | General | $47,202 | 35 | |
| 2021 | General | $6,760 | 16 | |
| 2020 | General | $11,366 | 4 | |
| 2020 | Research | $3,150 | 4 | |
| 2019 | General | $11,432 | 9 | |
| 2019 | Research | $830 | 2 |
Beside peers
- Maxim Mokin
- Vascular Neurology median
- Middle half of Vascular Neurology
- National median
In program year 2025, general payments to Maxim Mokin were reported at $16,532. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.
Show as a table
| Year | Maxim Mokin | Vascular Neurology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $11,432 | $263 | $102–$1,640 | $163 |
| 2020 | $11,366 | $153 | $45–$1,000 | $114 |
| 2021 | $6,760 | $261 | $100–$1,355 | $132 |
| 2022 | $47,202 | $242 | $87–$1,273 | $149 |
| 2023 | $27,883 | $322 | $97–$1,266 | $160 |
| 2024 | $15,570 | $247 | $70–$1,053 | $164 |
| 2025 | $16,532 | $360 | $91–$1,472 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
13
Drug cost
$5,580
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Brilinta Ticagrelor | Brand | 13 | $5,580 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 27 billing codesPaid by Medicare
$31,265
Medicare patients
48
Services billed
178
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 56% | |
| Arthritis | 56% | |
| Diabetes | 40% | |
| Atrial fibrillation | 40% | |
| Chronic kidney disease | 35% | |
| COPD | 35% | |
| Heart failure | 31% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
171 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Vascular Neurology in Florida
Robert Mannel
Vascular Neurology · Jacksonville Beach, FL
Alexander Senetar
Vascular Neurology · Sarasota, FL
Amin Aghaebrahim
Vascular Neurology · Jacksonville, FL
Miguel Chuquilin
Vascular Neurology · Tallahassee, FL
Richard Callison
Vascular Neurology · Fort Pierce, FL
Farah Fourcand
Vascular Neurology · Vero Beach, FL
Related records
Vascular Neurology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Vascular Neurology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.